cyc 202 has been researched along with glucuronic acid in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (glucuronic acid) | Trials (glucuronic acid) | Recent Studies (post-2010) (glucuronic acid) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 8,119 | 170 | 4,136 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blagoeva, E; Gaudinová, A; Malbeck, J; Vanek, T; Vanková, R | 1 |
1 other study(ies) available for cyc 202 and glucuronic acid
| Article | Year |
|---|---|
Cyclin-dependent kinase inhibitor, roscovitine, in combination with exogenous cytokinin, N6-benzyladenine, causes increase of cis-cytokinins in immobilized tobacco cells.
Topics: Adenine; Alginates; Benzyl Compounds; Cell Survival; Cells, Cultured; Cells, Immobilized; Cyclin-Dependent Kinases; Cytokinins; Glucuronic Acid; Hexuronic Acids; Isopentenyladenosine; Kinetin; Nicotiana; Purines; Reproducibility of Results; Roscovitine; Sensitivity and Specificity | 2003 |